RxDoctor Payments DataLook up a doctor →

Jateum Blackburn

Family · Cleveland, TNNPI 1265818983

Payments from drug & device makers

$143,199in general payments, 2019–2025

Across 1,572 payments — averaging $91.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$120K
  • Livanova USA, Inc.$2K
  • UCB, Inc.$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Biohaven Pharmaceutical Holding Company Ltd.$1K
  • EMD Serono, Inc.$1K
  • plus $15K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)481$120,498
Livanova USA, Inc.7$2,134
UCB, Inc.101$1,637
Biohaven Pharmaceuticals, Inc.94$1,347
Biohaven Pharmaceutical Holding Company Ltd.60$1,254
EMD Serono, Inc.44$1,220
Neurelis, Inc.47$1,090
Biogen55$1,040
AstraZeneca(2 entities)32$895
Teva Pharmaceuticals USA, Inc.43$876
Neurocrine Biosciences, Inc.47$827
Pfizer46$686
Acadia Pharmaceuticals Inc28$633
Lundbeck LLC32$630
Argenx US, Inc.40$613
Eisai Inc.31$610
Novartis33$604
Bristol Myers Squibb28$514
MDD US Operations, LLC9$487
Johnson & Johnson(2 entities)23$424
Lilly USA, LLC27$414
Kyowa Kirin, Inc.21$377
Sunovion Pharmaceuticals Inc.38$347
CSL Behring11$322
SK Life Science, Inc.14$283
Avanir Pharmaceuticals, Inc.16$219
Medtronic3$208
Amgen(2 entities)11$202
Upsher-smith Laboratories LLC8$190
Otsuka America Pharmaceutical, Inc.10$186
Amneal Pharmaceuticals LLC8$172
Catalyst Pharmaceuticals, Inc.7$159
Sumitomo Pharma America, Inc.17$157
E.r. Squibb & Sons, L.L.C.3$153
Banner Life Sciences, LLC9$146
Sanofi6$137
TG Therapeutics, Inc.6$134
Genentech USA, Inc.6$128
Corium, LLC9$124
Supernus Pharmaceuticals, Inc.7$112
Scilex Pharmaceuticals Inc.6$100
Jazz Pharmaceuticals Inc.4$92
Acorda Therapeutics, Inc6$90
Boston Scientific4$90
Axsome Therapeutics, Inc.4$87
Tanabe Pharma America, Inc.5$79
Amylyx Pharmaceuticals, Inc.3$75
Octapharma USA, Inc.3$61
Impel Pharmaceuticals Inc.3$50
Cycle Pharmaceuticals Inc2$41
Alnylam Pharmaceuticals Inc.2$40
Mallinckrodt Hospital Products Inc.2$36
Arbor Pharmaceuticals, Inc.2$28
Takeda Pharmaceuticals U.S.A., Inc.1$25
Merz Pharmaceuticals, LLC1$23
Sanofi-aventis U.S. LLC1$19
Impel Pharmaceuticals LLC1$17
Nevro Corp.1$16
Sandoz1$15
Vanda Pharmaceuticals Inc.1$15

How this compares

$143,199 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$26,163
Medicare patients
143
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Cleveland

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →